Polyvalent vaccine bronchovaxom (BV) was studied for efficacy against chronic obstructive bronchitis and bronchial asthma exacerbation. Good results were reported: reduction of disability duration, number of recurrences, cough intensity, discharged sputum. Laboratory tests discovered that BV brought about IgE decrease, IgA, T3, T4/T8 increase in bronchoalveolar lavage.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
chronic obstructive
8
obstructive bronchitis
8
bronchitis bronchial
8
[use bronchovaxom
4
bronchovaxom treatment
4
treatment patients
4
patients chronic
4
bronchial asthma]
4
asthma] polyvalent
4
polyvalent vaccine
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!